CT-Guided Iodine-125 seed Implantation for Postoperative Recurrent Triple-Negative Breast Cancer Complicated with Uremia: A Case Report
This case report demonstrates that CT-guided iodine-125 seed implantation is a safe and effective minimally invasive local treatment for controlling metastatic triple-negative breast cancer in patients with uremia who cannot tolerate systemic therapy.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Cancer treatment often relies on a two-pronged approach: attacking the tumor directly while managing the body's overall health. For many types of breast cancer, doctors can use hormone-blocking drugs or targeted therapies, but a specific and aggressive subtype known as triple-negative breast cancer lacks these targets. This means the standard defense is chemotherapy, which uses powerful drugs to kill rapidly dividing cells. However, these drugs must be filtered out of the body by the kidneys. When a patient suffers from uremia, a severe condition where the kidneys have failed and toxins build up in the blood, the body cannot safely process these chemotherapy drugs. The result is a difficult medical corner where the treatment needed to fight the cancer could be fatal due to kidney failure, leaving patients with few options other than managing symptoms without stopping the tumor's growth.
This story centers on a fifty-year-old woman who found herself in exactly this predicament. She had been living with kidney failure for over a decade, requiring regular sessions of hemodialysis to clean her blood. In 2024, she was diagnosed with triple-negative breast cancer. Because of her kidney condition, her doctors had to be extremely careful with her treatment plan. She underwent surgery to remove the tumor, followed by a course of chemotherapy. While the initial treatment showed some promise, she eventually had to stop taking her medication because her body could not tolerate it. By early 2025, the cancer had returned, spreading to a lymph node in her left armpit. Her doctors tried a different chemotherapy drug, but the lymph node continued to grow, and her kidney condition made it impossible to try stronger systemic treatments or immunotherapy. The cancer was winning, and the usual weapons were off-limits.
Facing a situation where the standard path was blocked, the medical team turned to a different strategy: a precise, local attack. Instead of flooding the entire body with drugs, they decided to treat the specific spot where the cancer had returned. On June 23, 2025, the patient underwent a procedure called CT-guided iodine-125 seed implantation. In this technique, doctors use a computerized tomography scan to create a detailed map of the body, allowing them to guide a needle directly into the cancerous lymph node. Through this needle, they placed forty-seven tiny radioactive seeds, each the size of a grain of rice, directly into the tumor. These seeds emit a low level of radiation continuously, acting like a slow-acting poison that kills the cancer cells right where they sit, while the radiation fades away quickly so it does not harm the surrounding healthy tissue.
The procedure was performed smoothly, and the patient's vital signs remained stable throughout. Because the treatment was local and did not rely on the kidneys to filter out drugs, it did not place extra stress on her already fragile renal system. In the months that followed, the medical team monitored her closely. They checked her blood work to ensure her kidney function and electrolyte levels remained steady, and they used CT scans to watch the tumor. Nine months after the seeds were placed, the results were clear. The cancerous lymph node in her armpit had stopped growing; it remained the same size, showing no signs of spreading or getting larger. Her blood tests confirmed that the seeds had not caused any new problems with her kidney failure or electrolyte balance. Furthermore, the physical discomfort she had felt from the swelling in her armpit disappeared, and her ability to move and perform daily tasks improved.
This case offers a glimpse into how medical science can adapt when standard protocols fail. The researchers found that for a patient with triple-negative breast cancer and severe kidney failure, this minimally invasive local treatment provided a way to control the disease without the toxic side effects of full-body chemotherapy. The seeds successfully halted the growth of the metastatic lymph node, and the patient's overall health remained stable. The doctors noted that while this approach worked well for this individual, it is a single story, and more research is needed to confirm if it is a reliable solution for everyone in similar situations. Nevertheless, the outcome demonstrates that when the body cannot handle the heavy burden of systemic drugs, a targeted, local approach can offer a safe and effective alternative to stop the cancer in its tracks.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.